About Immunotherapy

What is Immunotherapy?

Immunotherapy is a drug treatment that uses the human body’s own immune system to fight cancer.  It may be administered to patients intravenously in the Chemotherapy Unit of the hospital, but it is not the same as chemotherapy.

A number of cancer immunotherapies have been developed using different strategies to help boost the body’s immune response. Some immunotherapies help your immune system attack the cancer directly and some help to enhance your body’s immune response to fight the cancer. For example, some cancers trick the immune system by switching off certain pathways so that cancer cells are no longer recognized, allowing them to continue to grow. One type of immunotherapy helps fight cancer by switching on the pathways that the cancer cells have switched off, so that the immune system begins to recognize and attack the cancer. There are several other approaches to cancer immunotherapy as well.

There are different immunotherapies available in Canada to treat skin melanoma. In general, all treatment options can cause serious side effects; in some cases, there is even a risk of fatal side effects. That’s why it is always important to carefully weigh the benefits of any cancer treatment against the possible risks. You should discuss possible side effects with your doctor before starting treatment.

Click here to read more about these treatments.

(Source: www.redefining-cancer-treatment.ca)

Medical advancements, like immunotherapy, give patients the ability to fight cancer with everything they have – including their own cells. Witness the destruction of a cancer cell: Cells #GoBoldly

For more information about immunotherapy for non-melanoma skin cancers (NMSC), please click here: The biology of non-melanoma skin cancers and their strong immunogenicity makes these tumors good candidates for novel and emerging immunotherapeutic agents.

NCCN Guidelines for Patients Explain How to Recognize and Manage Immunotherapy-Related Toxicities, July 2020:

Click here to view the new NCCN Guidelines for Patients®: Immunotherapy Side Effects series

Also available: Clinical Practice Guidelines by National Comprehensive Cancer Network ~ Management of Immunotherapy-Related Toxicities.  Version 1.2018, February 14, 2018  Source: NCCN.org

Click here to visit:

AIM with Immunotherapy Resources for Canadian Health Care Providers

• • Pembrolizumab
    • Melanoma
  • Nivolumab
    • Melanoma
  • Nivolumab/Ipilimumab
    • Melanoma
  • Ipilimumab
    • Melanoma

Additional information and resources can be viewed or downloaded at PeerVoice. PeerVoice activities are designed to fill the unmet needs of the medical community by reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. These verbal interview-style presentations are also available as downloadable transcripts, click here to view or read the presentations:

Advances in Adjuvant Melanoma Therapy

Minding the Melanoma Patient With Brain Metastases: Updates to Personalize Care

Check back regularly for new PeerVoice activities:About PeerVoice

This informational video is also available in French. Created by Teresa Petrella, BSc, MD, MSc, FRCPC – Medical Oncologist, Associate Professor, University of Toronto; and the team at Odette Cancer Centre, Sunnybrook Health Sciences Centre, as well as the Members of the Canadian Melanoma Task Force.

This informational video is also available in French, Cantonese, Punjabi, Spanish, Japanese, German, and Italian. Created by Massey Nematollahi, RN, CNS, OCN, CON, Immuno-Oncology Clinical Nurse Specialist, William Osler Health System and Dr. Parneet Cheema, HBSc, MD, MBiotech, FRCPC, Assistant Professor, University of Toronto, Medical Oncologist, William Osler Health System

Click this image to view the full infographic atCONECTed.io

An up-to-date list of available treatments can be found on the Canadian Agency for Drugs and Technologies in Health (CADTH) website’s Provincial drug formulary database, which can be accessed here. For more information about immunotherapy and BRAF inhibitor therapies and whether they might be an option for you, ask your Doctor.

Listed above are a few sources of information and support you might find useful. These groups are not connected to Save Your Skin Foundation. We are providing the links as useful sources of information but do not monitor content for accuracy and quality.

NOTE: The information on the Save Your Skin website is not intended to replace the medical advice of a doctor or healthcare provider. While we make every effort to ensure that the information on our site is as current as possible, please note that information and statistics are subject to change as new research and studies are published.